{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-010768","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2022-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.520038+00:00","generated_at":"2026-06-27T01:30:56.046615+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"OptimizeRx adopts 2022 Cash Bonus Plan; CCO salary $350k, GC $296k","bullets":["Compensation Committee adopted 2022 Cash Bonus Plan aligning officer pay with strategic goals.","Stephen Silvestro (CCO) base salary increased to $350,000; bonus target set at 60% of base.","Marion Odence-Ford (GC/Chief Compliance Officer) base salary $296,000; bonus target 40% of base.","Employment agreements amended for both executives effective Feb 28, 2022, with eligibility for cash/equity incentives.","Annual meeting scheduled for June 9, 2022; stockholder proposals due by March 14, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-010768","json":"https://secwatch.observer/filing/0001213900-22-010768.json","markdown":"https://secwatch.observer/filing/0001213900-22-010768.md","text":"https://secwatch.observer/filing/0001213900-22-010768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022010768/0001213900-22-010768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022010768/ea156483-8k_optimizerx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T01:30:56.046615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}